Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design
Citations Over TimeTop 10% of 2015 papers
Abstract
Myeloid cell leukemia-1 (Mcl-1) is an antiapoptotic member of the Bcl-2 family of proteins that is overexpressed and amplified in many cancers. Overexpression of Mcl-1 allows cancer cells to evade apoptosis and contributes to the resistance of cancer cells to be effectively treated with various chemotherapies. From an NMR-based screen of a large fragment library, several distinct chemical scaffolds that bind to Mcl-1 were discovered. Here, we describe the discovery of potent tricyclic 2-indole carboxylic acid inhibitors that exhibit single digit nanomolar binding affinity to Mcl-1 and greater than 1700-fold selectivity over Bcl-xL and greater than 100-fold selectivity over Bcl-2. X-ray structures of these compounds when complexed to Mcl-1 provide detailed information on how these small-molecules bind to the target, which was used to guide compound optimization.
Related Papers
- → A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders(1989)94 cited
- → Fluoxetine‐Induced Tricyclic Toxicity: Extent and Duration(1991)45 cited
- Effect of tricyclic antidepressants on individual symptoms.(1980)
- → Psychiatric Side Effects of Tricyclic Antidepressants(1990)3 cited
- Antidepressants in older persons.(2006)